iShares Health Innovation Active ETF (NYSEARCA:BMED) Short Interest Update

iShares Health Innovation Active ETF (NYSEARCA:BMED) was the target of a significant increase in short interest in the month of July. As of July 31st, there was short interest totaling 8,033 shares, an increase of 621.1% from the July 15th total of 1,114 shares. Currently, 2.2% of the shares of the stock are sold short. Based on an average trading volume of 1,025 shares, the days-to-cover ratio is currently 7.8 days.

Hedge Funds Weigh In On iShares Health Innovation Active ETF

A hedge fund recently bought a new stake in iShares Health Innovation Active ETF stock. Comprehensive Financial Planning Inc. PA purchased a new stake in iShares Health Innovation Active ETF (NYSEARCA:BMED) during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund purchased 10,832 shares of the company’s stock, valued at approximately $309,000. Comprehensive Financial Planning Inc. PA owned approximately 3.01% of iShares Health Innovation Active ETF at the end of the most recent reporting period.

iShares Health Innovation Active ETF Stock Down 0.3%

NYSEARCA:BMED opened at $32.35 on Friday. The firm has a market capitalization of $11.65 million, a PE ratio of 24.91 and a beta of 0.73. iShares Health Innovation Active ETF has a 12-month low of $25.52 and a 12-month high of $32.45. The firm has a 50-day moving average price of $30.37 and a 200 day moving average price of $29.63.

About iShares Health Innovation Active ETF

The BlackRock Future Health ETF (BMED) is an exchange-traded fund that is based on the MSCI All Country World index. The fund is actively managed to invest in global equities in the health sciences industry. BMED was launched on Sep 29, 2020 and is managed by BlackRock.